Drug Approval | January 23, 2024
EMA grants ODD to GC Biopharma's treatment for Sanfilippo Syndrome
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Automated parallel capillary electrophoresis system simplifies protein analysis
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
The latest upgraded Tele Clinic is Artificial Intelligence (AI) - driven to provide healthcare facilities in far flung areas of the region, where such facilities are either not available or inadequately available
Subscribe To Our Newsletter & Stay Updated
